Stockreport

Novo Nordisk Wegovy Data Challenges Foundayo And Resets Valuation Debate [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Novo Nordisk released new cross trial data indicating its oral Wegovy pill produces greater weight loss than Eli Lilly's newly FDA approved obesity pill Foundayo. The [Read more]